Immunological changes in a case of Marchiafava-Bignami disease: response to amineptine treatment

Author： Humbert T.   Bureau J.   Chabrand P.  

Publisher： Elsevier

ISSN： 0924-9338

Source： European Psychiatry, Vol.10, Iss.2, 1995-01, pp. : 107-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinicoradiologic subtypes of Marchiafava-Bignami disease

By Heinrich Alexander   Runge Uwe   Khaw Alexander  

Journal of Neurology, Vol. 251, Iss. 9, 2004-09 ,pp. : 1050-1059

Springer Publishing Company

Access to resources Recommend Favorite

Immunological approach for the treatment of Alzheimer’s disease

By Solomon Beka  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 283-286

Humana Press, Inc

Access to resources Recommend Favorite

Immunological markers of disease activity in MS

By Hartung H.-P.  

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 55-56

Elsevier

Access to resources Recommend Favorite

Parkinson's Disease: The Case for Novel Treatment Strategies

By Stern M.B.   Freese A.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 2-3

Elsevier

Access to resources Recommend Favorite

The prediction of response to Galantamine treatment in Patients with mild to moderate Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 2, 2014-02 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite